Usefulness of ischemia-modified albumin in the diagnosis of sepsis/septic shock in the emergency department

다국어 초록 (Multilingual Abstract)

Objective No studies have evaluated the diagnostic value of ischemia-modified albumin (IMA) for the early detection of sepsis/septic shock in patients presenting to the emergency department (ED). We aimed to assess the usefulness of IMA in diagnosing sepsis/septic shock in the ED. Methods This retrospective, observational study analyzed IMA, lactate, high sensitivity C-reactive protein, and procalcitonin levels measured within 1 hour of ED arrival. Patients with suspected infection meeting at least two systemic inflammatory response syndrome criteria were included and classified into the infection, sepsis, and septic shock groups using Sepsis-3 definitions. Areas under the receiver operating characteristic curves (AUCs) with 95% confidence intervals (CIs) and multivariate logistic regression were used to determine diagnostic performance. Results This study included 300 adult patients. The AUC (95% CI) of IMA levels (cut-off ≥85.5 U/mL vs. ≥87.5 U/mL) was higher for the diagnosis of sepsis than for that of septic shock (0.729 [0.667–0.791] vs. 0.681 [0.613–0.824]) and was higher than the AUC of procalcitonin levels (cut-off ≥1.58 ng/mL, 0.678 [0.613–0.742]) for the diagnosis of sepsis. When IMA and lactate levels were combined, the AUCs were 0.815 (0.762–0.867) and 0.806 (0.754–0.858) for the diagnosis of sepsis and septic shock, respectively. IMA levels independently predicted sepsis (odds ratio, 1.05; 95% CI, 1.00–1.09; P=0.029) and septic shock (odds ratio, 1.07; 95% CI, 1.02–1.11; P=0.002). Conclusion Our findings indicate that IMA levels are a useful biomarker for diagnosing sepsis/septic shock early, and their combination with lactate levels can enhance the predictive power for early diagnosis of sepsis/septic shock in the ED.

참고문헌 (Reference)

1 Dorsett M, "qSOFA has poor sensitivity for prehospital identification of severe sepsis and septic shock" 21 : 489-497, 2017

2 Turedi S, "The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism" 9 : 49-, 2008

3 Singer M, "The Third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3)" 315 : 801-810, 2016

4 Williams JM, "Systemic inflammatory response syndrome, quick sequential organ function assessment, and organ dysfunction: insights from a prospective database of ED patients with infection" 151 : 586-596, 2017

5 Dellinger RP, "Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012" 39 : 165-228, 2013

6 Dellinger RP, "Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock" 32 : 858-873, 2004

7 Dellinger RP, "Surviving Sepsis Campaign : international guidelines for management of severe sepsis and septic shock : 2008" 34 : 17-60, 2008

8 Rhodes A, "Surviving Sepsis Campaign : international guidelines for management of sepsis and septic shock : 2016" 45 : 486-552, 2017

9 Hausfater P, "Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department" 11 : R60-, 2007

10 Freund Y, "Serum lactate and procalcitonin measurements in emergency room for the diagnosis and risk-stratification of patients with suspected infection" 17 : 590-596, 2012

11 Yerlikaya FH, "Serum ischemia-modified albumin levels at diagnosis and during treatment of late-onset neonatal sepsis" 27 : 1723-1727, 2014

12 Bakker J, "Serial blood lactate levels can predict the development of multiple organ failure following septic shock" 171 : 221-226, 1996

13 Martin GS, "Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes" 10 : 701-706, 2012

14 Sinha MK, "Role of “Ischemia modified albumin”, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes" 90 : 644-, 2004

15 Singer AJ, "Quick SOFA scores predict mortality in adult emergency department patients with and without suspected infection" 69 : 475-479, 2017

16 Schmidt de Oliveira-Netto AC, "Procalcitonin, C-reactive protein, albumin, and blood cultures as early markers of sepsis diagnosis or predictors of outcome: a prospective analysis" 12 : 2632010-2632019, 2019

17 Miglietta F, "Procalcitonin, C-reactive protein and serum lactate dehydrogenase in the diagnosis of bacterial sepsis, SIRS and systemic candidiasis" 23 : 230-237, 2015

18 Spoto S, "Procalcitonin and MR-proadrenomedullin combination with SOFA and qSOFA scores for sepsis diagnosis and prognosis : a diagnostic algorithm" 50 : 44-52, 2018

19 Puskarich MA, "One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock : a before and after study" 13 : R167-, 2009

20 Lin S, "Novel biomarkers in diagnosing cardiac ischemia in the emergency department : a systematic review" 83 : 684-691, 2012

21 Beal AL, "Multiple organ failure syndrome in the 1990s : systemic inflammatory response and organ dysfunction" 271 : 226-233, 1994

22 Ashok Kumar P, "Multiple biomarkers to assess the pathophysiological state in critically ill patients with sepsis" 31 : 310-314, 2016

23 Shetty A, "Lactate ≥2 mmol/L plus qSOFA improves utility over qSOFA alone in emergency department patients presenting with suspected sepsis" 29 : 626-634, 2017

24 Abboud H, "Ischemia-modified albumin in acute stroke" 23 : 216-220, 2007

25 Zapico-Muniz E, "Ischemia-modified albumin during skeletal muscle ischemia" 50 : 1063-1065, 2004

26 Khashana A, "Ischemia modified albumin in early neonatal sepsis" 48 : 488-489, 2016

27 Balta S, "Ischemia modified albumin in cardiovascular disease" 34 : 1699-, 2016

28 Chamberlain DJ, "Identification of the severe sepsis patient at triage : a prospective analysis of the Australasian Triage Scale" 32 : 690-697, 2015

29 Weiss SL, "Elevated malondialdehyde levels in sepsis : something to ‘stress’ about" 18 : 125-, 2014

30 Nguyen HB, "Early lactate clearance is associated with improved outcome in severe sepsis and septic shock" 32 : 1637-1642, 2004

31 Rivers E, "Early goal-directed therapy in the treatment of severe sepsis and septic shock" 345 : 1368-1377, 2001

32 Ljungstrom L, "Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis" 12 : e0181704-, 2017

33 Rodriguez RM, "Comparison of qSOFA with current emergency department tools for screening of patients with sepsis for critical illness" 35 : 350-356, 2018

34 Luzzani A, "Comparison of procalcitonin and C-reactive protein as markers of sepsis" 31 : 1737-1741, 2003

35 Prashanth AK, "Clinical significance of ischemia modified albumin in critically ill patients with sepsis" 30 : 194-197, 2015

36 Bar-Or D, "Characterization of the Co(2+)and Ni(2+)binding amino-acid residues of the N-terminus of human albumin : an insight into the mechanism of a new assay for myocardial ischemia" 268 : 42-47, 2001

37 Montagnana M, "Biochemical markers of acute intestinal ischemia : possibilities and limitations" 6 : 341-, 2018

38 Galley HF, "Bench-to-bedside review : targeting antioxidants to mitochondria in sepsis" 14 : 230-, 2010

39 Erdem SS, "Association between ischemia-modified albumin, homocysteine, vitamin B(12) and folic acid in patients with severe sepsis" 50 : 1417-1421, 2012

40 Lippi G, "Academy of Emergency Medicine and Care-Society of Clinical Biochemistry and Clinical Molecular Biology consensus recommendations for clinical use of sepsis biomarkers in the emergency department" 13 : 6877-, 2017

41 Bar-Or D, "A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report" 19 : 311-315, 2000